Levy Adam Scott

Avg. Two Year Performance

(85%) Avg. Purchase Return
(36%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return33%40%7%(44%)(85%)
Purchase Success Rate2 of 22 of 22 of 20 of 20 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Vical Inc.

Drugs » Biotechnology

Chief Business Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Viridian Therapeutics, Inc....

Health Services » Medical Laboratories & Research

Chief Business Officer:

Holdings: 10.54K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Mineralys Therapeutics, Inc.

Other » Other

CFO and Secretary:

Holdings: 236.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($146.00K) Net Amount
Buy:0--
Sell:($146.00K)$13.57